Back

InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma

Orlow, I.; Sadeghi, K. D.; Edmiston, S. N.; Kenney, J. M.; Lezcano, C.; Wilmott, J. S.; Cust, A. E.; Scolyer, R. A.; Mann, G. J.; Lee, T. K.; Burke, H.; Jakrot, V.; Shang, P.; Ferguson, P. M.; Boyce, T. W.; Funchain, P.; Ko, J. S.; Ngo, P.; Rees, J. R.; OConnell, K.; Hao, H.; Parrish, E.; Conway, K.; Googe, P. B.; Ollila, D. W.; Moschos, S. J.; Hernando, E.; Hanniford, D.; Argibay, D.; Amos, C. I.; Lee, J. E.; Osman, I.; Luo, L.; Kuan, P.-F.; Aurora, A.; Gould Rothberg, B. E.; Bosenberg, M. W.; Gerstenblith, M. R.; Thompson, C.; Bogner, P. N.; Gorlov, I. P.; Holmen, S. L.; Brunsgaard, E. K.; S

2022-05-23 epidemiology
10.1101/2022.05.21.22275329 medRxiv
Show abstract

IntroductionWe are conducting a multicenter study to identify classifiers predictive of disease-specific survival in patients with primary melanomas. Here we delineate the unique aspects, challenges, and best practices for optimizing a study of generally small-sized pigmented tumor samples including primary melanomas of at least 1.05mm from AJTCC TNM stage IIA-IIID patients. This ongoing study will target 1,000 melanomas within the international InterMEL consortium. We also evaluated tissue-derived predictors of extracted nucleic acids quality and success in downstream testing. MethodsFollowing a pre-established protocol, participating centers ship formalin-fixed paraffin embedded (FFPE) tissue sections to Memorial Sloan Kettering Cancer Center for the centralized handling, dermatopathology review and histology-guided coextraction of RNA and DNA. Samples are distributed for evaluation of somatic mutations using next gen sequencing (NGS) with the MSK-IMPACT assay, methylation-profiling (array), and miRNA expression (Nanostring nCounter). ResultsSufficient material was obtained for screening of miRNA expression in 683/685 (99%) eligible melanomas, methylation in 467 (68%), and somatic mutations in 560 (82%). In 446/685 (65%) cases, aliquots of RNA/DNA were sufficient for testing with all three platforms. Among samples evaluated by the time of this analysis, the mean NGS coverage was 249x, 59 (18.6%) samples had coverage below 100x, and 41/414 (10%) failed methylation QC due to low intensity probes or insufficient Meta-Mixed Interquartile (BMIQ)- and single sample (ss)- Noob normalizations. Six of 683 RNAs (1%) failed Nanostring QC due to the low proportion of probes above the minimum threshold. Age of the FFPE tissue blocks (p<0.001) and time elapsed from sectioning to co-extraction (p=0.002) were associated with methylation screening failures. Melanin reduced the ability to amplify fragments of 200bp or greater (absent/lightly pigmented vs heavily pigmented, p<0.003). Conversely, heavily pigmented tumors rendered greater amounts of RNA (p<0.001), and of RNA above 200 nucleotides (p<0.001). ConclusionOur experience with many archival tissues demonstrates that with careful management of tissue processing and quality control it is possible to conduct multi-omic studies in a complex multi-institutional setting for investigations involving minute quantities of FFPE tumors, as in studies of early-stage melanoma.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.